Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.

Sax PE, Wohl D, Yin MT, Post F, DeJesus E, Saag M, Pozniak A, Thompson M, Podzamczer D, Molina JM, Oka S, Koenig E, Trottier B, Andrade-Villanueva J, Crofoot G, Custodio JM, Plummer A, Zhong L, Cao H, Martin H, Callebaut C, Cheng AK, Fordyce MW, McCallister S; GS-US-292-0104/0111 Study Team.

Lancet. 2015 Jun 27;385(9987):2606-15. doi: 10.1016/S0140-6736(15)60616-X. Epub 2015 Apr 15. Erratum in: Lancet. 2016 Apr 30;387(10030):1816.

PMID:
25890673
2.

[Etravirine in highly treatment-experienced patients].

Palter DP, Corbera EF, Tiraboschi JM.

Enferm Infecc Microbiol Clin. 2009 Dec;27 Suppl 2:6-11. doi: 10.1016/S0213-005X(09)73213-6. Review. Spanish.

PMID:
20116622
3.

Association of HIV transmission categories with sociodemographic, viroimmunological and clinical parameters of HIV-infected patients.

Collazos J, Asensi V, Carton JA; Grupo Español para el Estudio Multifactorial de la Adherencia (GEEMA).

Epidemiol Infect. 2010 Jul;138(7):1016-24. doi: 10.1017/S0950268809991282. Epub 2009 Nov 27.

PMID:
19941690
4.

CD4 responses in the setting or suboptimal virological responses to antiretroviral therapy: features, outcomes, and associated factors.

Collazos J, Asensi V, Cartón JA; Grupo Español para el Estudio Multifactorial de la Adherencia (Geema).

AIDS Res Hum Retroviruses. 2009 Jul;25(7):647-55. doi: 10.1089/aid.2008.0098.

PMID:
19621987

Supplemental Content

Loading ...
Support Center